DK1831240T3 - 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse - Google Patents

18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse

Info

Publication number: DK1831240T3
Authority: DK; Denmark
Prior art keywords: 17pregn; carbolactones; ene; methyl; pharmaceutical preparations
Prior art date: 2004-12-30

Application number

DK05850392T

Other languages

English (en)

Inventor

Rolf Bohlmann

Dieter Bittler

Hermann Kuenzer

Peter Esperling

Hans-Peter Muhn

Karl-Heinrich Fritzemeier

Ulrike Fuhrmann

Katja Prelle

Frueher Kurz Steffen Borden

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-30

Filing date

2005-12-30

Publication date

2009-11-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36087369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1831240(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-30 Application filed by Schering Ag filed Critical Schering Ag

2009-11-23 Application granted granted Critical

2009-11-23 Publication of DK1831240T3 publication Critical patent/DK1831240T3/da

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DK05850392T 2004-12-30 2005-12-30 18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse DK1831240T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004063864A DE102004063864A1 (de)	2004-12-30	2004-12-30	18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
PCT/EP2005/014205 WO2006072467A1 (de)	2004-12-30	2005-12-30	18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische präparate

Publications (1)

Publication Number	Publication Date
DK1831240T3 true DK1831240T3 (da)	2009-11-23

Family

ID=36087369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05850392T DK1831240T3 (da)	2004-12-30	2005-12-30	18-methyl-19-nor-17pregn-4-en-21, 17-carbolactoner samt farmaceutiske præparater, der indeholder disse

Country Status (32)

Country	Link
US (1)	US20090029953A1 (da)
EP (1)	EP1831240B8 (da)
JP (1)	JP5043681B2 (da)
KR (1)	KR20070093443A (da)
CN (1)	CN101128476B (da)
AR (1)	AR052657A1 (da)
AU (1)	AU2005324055A1 (da)
BR (1)	BRPI0518533A2 (da)
CA (1)	CA2594171C (da)
CR (1)	CR9223A (da)
CY (1)	CY1109498T1 (da)
DE (2)	DE102004063864A1 (da)
DK (1)	DK1831240T3 (da)
EA (1)	EA014325B1 (da)
ES (1)	ES2331322T3 (da)
GT (1)	GT200500394A (da)
IL (1)	IL184288A (da)
MX (1)	MX2007008074A (da)
MY (1)	MY145904A (da)
NO (1)	NO20073257L (da)
NZ (1)	NZ556150A (da)
PA (1)	PA8658401A1 (da)
PE (2)	PE20060853A1 (da)
PL (1)	PL1831240T3 (da)
PT (1)	PT1831240E (da)
RS (1)	RS51128B (da)
SI (1)	SI1831240T1 (da)
TW (1)	TW200635942A (da)
UA (1)	UA90496C2 (da)
UY (1)	UY29320A1 (da)
WO (1)	WO2006072467A1 (da)
ZA (1)	ZA200706254B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006030416A1 (de) *	2006-06-29	2008-01-03	Bayer Schering Pharma Ag	18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007027636A1 (de) *	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) *	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de)	2007-06-12	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de) *	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de)	2007-12-29	2009-09-17	Bayer Schering Pharma Aktiengesellschaft	19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063498A1 (de) *	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de)	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063499A1 (de) *	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) *	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2265629B1 (en) *	2008-03-05	2015-06-24	Evestra, Inc.	Bismethylene-17 carbolactones and related uses
DE102008026793A1 (de)	2008-06-02	2009-12-03	Bayer Schering Pharma Aktiengesellschaft	C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
CN101623287B (zh) *	2008-07-07	2012-02-08	天津金耀集团有限公司	一种屈螺酮类似物的治疗更年期综合症的药物组合物
US8222237B2 (en) *	2008-11-25	2012-07-17	Evestra, Inc.	Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
WO2010066349A1 (de) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	Verwendung von 17beta-cyano-19-androst-4-en-derivaten zur herstellung eines arzneimittels in depot-form zur parenteralen anwendung sowie depot-arzneimittel enthaltend 17beta-cyano-19-androst-4-en-derivate zur parenteralen anwendung
WO2010066354A1 (de) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	VERWENDUNG VON 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG
WO2010066355A1 (de) *	2008-12-12	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	VERWENDUNG VON 17β- CYANO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG
WO2012059594A1 (en)	2010-11-04	2012-05-10	Bayer Pharma Aktiengesellschaft	Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3959322A (en) *	1960-09-22	1976-05-25	Herchel Smith	Synthesis of 13-alkyl-gon-4-ones
DE3022337A1 (de) *	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3402329A1 (de) *	1984-01-20	1985-08-01	Schering AG, 1000 Berlin und 4709 Bergkamen	6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2739029B1 (fr) *	1995-09-21	1997-11-21	Roussel Uclaf	Nouvelle application therapeutique des composes antimineralo-corticoides
DE19651000A1 (de) *	1996-12-01	1998-06-04	Schering Ag	Oxyiminopregnancarbolactone

2004
- 2004-12-30 DE DE102004063864A patent/DE102004063864A1/de not_active Ceased
2005
- 2005-12-28 UY UY29320A patent/UY29320A1/es not_active Application Discontinuation
- 2005-12-28 AR ARP050105574A patent/AR052657A1/es unknown
- 2005-12-29 TW TW094147315A patent/TW200635942A/zh unknown
- 2005-12-29 MY MYPI20056249A patent/MY145904A/en unknown
- 2005-12-29 GT GT200500394A patent/GT200500394A/es unknown
- 2005-12-29 PA PA20058658401A patent/PA8658401A1/es unknown
- 2005-12-30 KR KR1020077017382A patent/KR20070093443A/ko not_active Ceased
- 2005-12-30 BR BRPI0518533-5A patent/BRPI0518533A2/pt not_active IP Right Cessation
- 2005-12-30 SI SI200530803T patent/SI1831240T1/sl unknown
- 2005-12-30 DK DK05850392T patent/DK1831240T3/da active
- 2005-12-30 JP JP2007548774A patent/JP5043681B2/ja not_active Expired - Fee Related
- 2005-12-30 AU AU2005324055A patent/AU2005324055A1/en not_active Abandoned
- 2005-12-30 PT PT05850392T patent/PT1831240E/pt unknown
- 2005-12-30 US US11/813,251 patent/US20090029953A1/en not_active Abandoned
- 2005-12-30 RS RSP-2009/0443A patent/RS51128B/sr unknown
- 2005-12-30 CA CA2594171A patent/CA2594171C/en not_active Expired - Fee Related
- 2005-12-30 EP EP05850392A patent/EP1831240B8/de not_active Expired - Lifetime
- 2005-12-30 WO PCT/EP2005/014205 patent/WO2006072467A1/de not_active Ceased
- 2005-12-30 PL PL05850392T patent/PL1831240T3/pl unknown
- 2005-12-30 ES ES05850392T patent/ES2331322T3/es not_active Expired - Lifetime
- 2005-12-30 MX MX2007008074A patent/MX2007008074A/es active IP Right Grant
- 2005-12-30 DE DE502005007723T patent/DE502005007723D1/de not_active Expired - Lifetime
- 2005-12-30 NZ NZ556150A patent/NZ556150A/en not_active IP Right Cessation
- 2005-12-30 CN CN2005800486803A patent/CN101128476B/zh not_active Expired - Fee Related
- 2005-12-30 UA UAA200708684A patent/UA90496C2/ru unknown
- 2005-12-30 EA EA200701239A patent/EA014325B1/ru not_active IP Right Cessation
2006
- 2006-01-03 PE PE2006000006A patent/PE20060853A1/es not_active Application Discontinuation
- 2006-01-03 PE PE2009001212A patent/PE20100736A1/es not_active Application Discontinuation
2007
- 2007-06-25 NO NO20073257A patent/NO20073257L/no not_active Application Discontinuation
- 2007-06-28 IL IL184288A patent/IL184288A/en not_active IP Right Cessation
- 2007-07-03 CR CR9223A patent/CR9223A/es not_active Application Discontinuation
- 2007-07-27 ZA ZA200706254A patent/ZA200706254B/xx unknown
2009
- 2009-10-15 CY CY20091101073T patent/CY1109498T1/el unknown

Also Published As

Publication number	Publication date
CY1109498T1 (el)	2014-08-13
PL1831240T3 (pl)	2010-01-29
EP1831240A1 (de)	2007-09-12
CN101128476B (zh)	2011-02-09
WO2006072467A1 (de)	2006-07-13
PA8658401A1 (es)	2006-08-03
UY29320A1 (es)	2006-07-31
CA2594171C (en)	2012-10-16
SI1831240T1 (sl)	2009-12-31
PE20060853A1 (es)	2006-09-15
RS51128B (sr)	2010-10-31
EP1831240B1 (de)	2009-07-15
AR052657A1 (es)	2007-03-28
MX2007008074A (es)	2008-03-10
AU2005324055A1 (en)	2006-07-13
PT1831240E (pt)	2009-10-22
PE20100736A1 (es)	2010-12-03
IL184288A (en)	2011-06-30
TW200635942A (en)	2006-10-16
HK1112627A1 (en)	2008-09-12
MY145904A (en)	2012-05-15
NO20073257L (no)	2007-08-29
EA014325B1 (ru)	2010-10-29
GT200500394A (es)	2006-08-01
ES2331322T3 (es)	2009-12-29
JP2008526709A (ja)	2008-07-24
US20090029953A1 (en)	2009-01-29
KR20070093443A (ko)	2007-09-18
BRPI0518533A2 (pt)	2008-11-25
IL184288A0 (en)	2007-10-31
JP5043681B2 (ja)	2012-10-10
NZ556150A (en)	2011-02-25
DE102004063864A1 (de)	2006-07-13
UA90496C2 (ru)	2010-05-11
CN101128476A (zh)	2008-02-20
DE502005007723D1 (de)	2009-08-27
CA2594171A1 (en)	2006-07-13
EP1831240B8 (de)	2010-02-17
EA200701239A1 (ru)	2007-12-28
CR9223A (es)	2007-11-23
ZA200706254B (en)	2008-12-31

Publication	Publication Date	Title
NO20052285D0 (no)	2005-05-10	Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse
KR20050009999A (ko)	2005-01-26	약제학적 제제
ZA200706254B (en)	2008-12-31	18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
HUE061246T2 (hu)	2023-06-28	HFO-1234ze és HFC-134a tartalmú készítmények
MA28489B1 (fr)	2007-03-01	Preparations pharmaceutiques
EP1895838A4 (en)	2013-03-06	COMPOSITIONS AND METHODS
HUE043301T2 (hu)	2019-08-28	Botulinum-neurotoxint tartalmazó gyógyászati készítmények
NL1025404A1 (nl)	2004-08-09	Pyrazolo-triazine verbindingen en gebruik daarvan.
PL382306A1 (pl)	2007-08-20	Preparaty przeciwwirusowe do stosowania miejscowego
EP1784219A4 (en)	2010-02-17	STABILIZING FORMULATIONS
ZA200900673B (en)	2010-04-28	18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
DE602004028875D1 (de)	2010-10-07	Turboladergehäuse, turbolader und multiturboladersystem
GB0420062D0 (en)	2004-10-13	Assay methods,materials and preparations
DK1898863T3 (da)	2011-08-29	Etui til optagelse af en lægemiddelspakning samt anvendelse deraf
DK1773796T3 (da)	2010-06-21	Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
DK1768691T3 (da)	2013-07-01	Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
EP1786431A4 (en)	2012-06-13	IMPROVED PHOTOSENSITIZER FORMULATIONS AND THEIR USE
IL180229A0 (en)	2007-07-04	PROTEIN COMPLEX CONTAINING A HEMAGGLUTININ AND A POLYPEPTIDE-Hc-CONJUGATE AND METHODS FOR THE PREPARATION THEREOF
DK1768988T3 (da)	2009-04-20	Hidtil ukendte phenyl-borsyre-derivater samt fremgangsmåder til fremstilling deraf
SE0502071L (sv)	2007-03-20	Förpackning, förslutningsanordning samt användning därav
EP1660088A4 (en)	2009-04-29	PYRIDOMORPHINANE, PYRIDAZINOMORPHINANE AND ITS USE
DK1729734T3 (da)	2008-06-16	Spröjtetörrede farmaceutiske præparater
FI8053U1 (fi)	2008-10-20	Macrogol valmiste
DK1781631T3 (da)	2012-05-14	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf